↓ Skip to main content

Survival and predictors of mortality among HIV-positive children on antiretroviral therapy in public hospitals

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, August 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Survival and predictors of mortality among HIV-positive children on antiretroviral therapy in public hospitals
Published in
Journal of Pharmaceutical Policy and Practice, August 2022
DOI 10.1186/s40545-022-00448-6
Pubmed ID
Authors

Yalemgeta Biyazin, Kalkidan Wondwossen, Azene Bantie Wubie, Melese Getachew, Bereket Gebremichael

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 10%
Student > Master 3 8%
Lecturer 2 5%
Researcher 2 5%
Student > Ph. D. Student 1 3%
Other 2 5%
Unknown 26 65%
Readers by discipline Count As %
Nursing and Health Professions 4 10%
Medicine and Dentistry 3 8%
Biochemistry, Genetics and Molecular Biology 2 5%
Mathematics 1 3%
Business, Management and Accounting 1 3%
Other 4 10%
Unknown 25 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2022.
All research outputs
#17,454,891
of 25,608,265 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#375
of 522 outputs
Outputs of similar age
#253,536
of 432,349 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#5
of 7 outputs
Altmetric has tracked 25,608,265 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 522 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,349 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.